{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:09:28Z","timestamp":1778926168756,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007001","name":"Small Business Innovative Research and Small Business Technology Transfer","doi-asserted-by":"publisher","award":["R43EY030798"],"award-info":[{"award-number":["R43EY030798"]}],"id":[{"id":"10.13039\/100007001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","award":["7103"],"award-info":[{"award-number":["7103"]}],"id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006370","name":"Small Business Innovation Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004972","name":"Maryland Industrial Partnerships","doi-asserted-by":"publisher","award":["MIPS7103"],"award-info":[{"award-number":["MIPS7103"]}],"id":[{"id":"10.13039\/100004972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23EY03525"],"award-info":[{"award-number":["K23EY03525"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR003098"],"award-info":[{"award-number":["UL1TR003098"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["SBIR R43EY030798"],"award-info":[{"award-number":["SBIR R43EY030798"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MIPS7103"],"award-info":[{"award-number":["MIPS7103"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xops.2025.100857","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:22:16Z","timestamp":1750101736000},"page":"100857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Retinal Blood Flow Decreases after Treatment with Bevacizumab for Retinopathy of Prematurity"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0613-667X","authenticated-orcid":false,"given":"Joyce","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3694-6361","authenticated-orcid":false,"given":"Shaiza","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7365-3236","authenticated-orcid":false,"given":"Jeong-Yoon","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0752-1261","authenticated-orcid":false,"given":"Christina","family":"Kilby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ria","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moran Roni","family":"Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9519-5290","authenticated-orcid":false,"given":"Sripriya","family":"Sundararajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Magder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0459-2445","authenticated-orcid":false,"given":"Avigyan","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-5996","authenticated-orcid":false,"given":"Abhishek","family":"Rege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8488-4023","authenticated-orcid":false,"given":"Janet L.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100857_bib1","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.ophtha.2021.05.031","article-title":"International classification of retinopathy of prematurity, third edition","volume":"128","author":"Chiang","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100857_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.xops.2025.100857_bib3","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.ophtha.2022.02.008","article-title":"Artificial intelligence for retinopathy of prematurity: validation of a vascular severity scale against international expert diagnosis","volume":"129","author":"Campbell","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100857_bib4","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.ophtha.2024.06.006","article-title":"Use of an artificial intelligence-generated vascular severity score improved plus disease diagnosis in retinopathy of prematurity","volume":"131","author":"Coyner","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100857_bib5","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.ophtha.2024.05.019","article-title":"P score: a reference image-based clinical grading scale for vascular change in retinopathy of prematurity","volume":"131","author":"Binenbaum","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100857_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.xops.2025.100857_bib7","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","article-title":"Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial","volume":"394","author":"Stahl","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.xops.2025.100857_bib8","article-title":"Retinal blood flow association with age and weight in infants at risk for retinopathy of prematurity","volume":"14","author":"Cho","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2025.100857_bib9","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.1038\/s41598-024-58523-8","article-title":"Ocular blood flow in preterm neonates","volume":"14","author":"Silverman","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2025.100857_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100463","article-title":"Association of speckle-based blood flow measurements and fluorescein angiography in infants with retinopathy of prematurity","volume":"4","author":"Shats","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2025.100857_bib11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41598-023-49964-8","article-title":"A pilot optical coherence tomography angiography classification of retinal neovascularization in retinopathy of prematurity","volume":"14","author":"Chen","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.xops.2025.100857_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1167\/iovs.15-17783","article-title":"Extrafoveal cone packing in eyes with a history of retinopathy of prematurity","volume":"57","author":"Ramamirtham","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100857_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/11206721231178062","article-title":"Retinal blood flow velocities in infants with retinopathy of prematurity after intravitreal administration of bevacizumab","volume":"34","author":"Mohr","year":"2024","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100857_bib14","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00417-018-4063-0","article-title":"Intravitreal bevacizumab treatment reduces ocular blood flow in retinopathy of prematurity: a four-case report","volume":"256","author":"Matsumoto","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2025.100857_bib15","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1007\/s10792-018-01064-7","article-title":"Comparison of fluorescein angiographic findings in type 1 and type 2 retinopathy of prematurity with intravitreal bevacizumab monotherapy and spontaneous regression","volume":"39","author":"Vural","year":"2019","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.xops.2025.100857_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2015.12.005","article-title":"Practice patterns in retinopathy of prematurity treatment for disease milder than recommended by guidelines","volume":"163","author":"Gupta","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100857_bib17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00417-020-04706-8","article-title":"Treatment of retinopathy of prematurity (ROP) outside International Classification of ROP (ICROP) guidelines","volume":"258","author":"Rajan","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2025.100857_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/jcm11010039","article-title":"Treatment outside the recommended guidelines for retinopathy of prematurity (ROP): prevalence, characteristics, and issues","volume":"11","author":"Lema\u00eetre","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.xops.2025.100857_bib19","doi-asserted-by":"crossref","first-page":"332.e1","DOI":"10.1016\/j.jaapos.2019.08.279","article-title":"Treatment of non-type 1 retinopathy of prematurity in the postnatal growth and retinopathy of prematurity (G-ROP) study","volume":"23","author":"Liu","year":"2019","journal-title":"J AAPOS"},{"key":"10.1016\/j.xops.2025.100857_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6266528","article-title":"Treatment for nontype 1 retinopathy of prematurity by intravitreal injection of antivascular endothelial growth factor drugs","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100857_bib21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ogla.2021.10.005","article-title":"Dynamic alterations in blood flow in glaucoma measured with laser speckle contrast imaging","volume":"5","author":"Vinnett","year":"2022","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.xops.2025.100857_bib22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1167\/iovs.09-4391","article-title":"Divergent roles of nitric oxide and rho kinase in vasomotor regulation of human retinal arterioles","volume":"51","author":"Hein","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100857_bib23","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1167\/iovs15-16950","article-title":"VEGF receptor-2-linked PI3K\/Calpain\/SIRT1 activation mediates retinal arteriolar dilations to VEGF and shear stress","volume":"56","author":"Hein","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100857_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10456-004-8272-2","article-title":"Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro","volume":"7","author":"Wang","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1016\/j.xops.2025.100857_bib25","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1167\/iovs.08-1780","article-title":"Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease","volume":"49","author":"Hartnett","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100857_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5301\/ejo.5000938","article-title":"Effect of intravitreal aflibercept on central retinal arterial blood flow in type 1 retinopathy of prematurity","volume":"27","author":"Sukgen","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100857_bib27","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00417-017-3756-0","article-title":"Retinal VEGF levels correlate with ocular circulation measured by a laser speckle-micro system in an oxygen-induced retinopathy rat model","volume":"255","author":"Matsumoto","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525001551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525001551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:38:30Z","timestamp":1778924310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525001551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2666914525001551"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100857","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal Blood Flow Decreases after Treatment with Bevacizumab for Retinopathy of Prematurity","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100857"}}